Israel: Body Vision Medical raises US$20m Series C

Dorian Averbuch, chief executive. Body Vision

Body Vision Medical, a commercial-stage medical device company specialising in lung cancer diagnostics and treatment through real-time software technologies, has closed US$20m in Series C funding. Proceeds will be used to streamline commercialisation and manufacturing activities for its LungVisionTM 2.0 Platform, which uses AI Tomography, fused imaging, cloud-based machine learning and multi-modality image registration. The LungVision…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »